Neuland Laboratories Limited
NSE NEULANDLAB.NS
Neuland Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2024: USD 1.10
Neuland Laboratories Limited Free Cash Flow Per Share is USD 1.10 for the year ending March 31, 2024, a -32.84% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
-
Neuland Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2023 was USD 1.63, a 527.04% change year over year.
-
Neuland Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2022 was USD -0.38, a -142.84% change year over year.
-
Neuland Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2021 was USD 0.89, a 911.35% change year over year.
-
Neuland Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2020 was USD 0.09, a 13.76% change year over year.
Key data
| Date | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|
Market news
Loading...
Don’t Miss A Beat
NSE: NEULANDLAB.NS
| CEO | Mr. Davuluri Sucheth Rao |
| IPO Date | Oct. 13, 2008 |
| Location | India |
| Headquarters | Phoenix IVY Building |
| Employees | 1,643 |
| Sector | Healthcare |
| Industries | |
Description
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Key trends
Past 5 years
StockViz Staff
February 6, 2025
Any question? Send us an email